Medicare Finally Says Yes to GLP-1s for Weight Loss
After years of denying coverage, Medicare is launching a new program that could make Ozempic and Wegovy way more affordable. Plus, surprising news about what these drugs do to your liver.
Medicare's Big U-Turn on Weight Loss Drugs
Here's something I never thought I'd be writing: Medicare is about to start covering GLP-1 medications for weight loss. Yes, really.
Starting this July, there's something called the "Medicare GLP-1 Bridge" launching, followed by the full BALANCE program (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) in January 2027. Right now, Medicare literally can't cover weight loss drugs - it's prohibited by law. And only 13 states cover GLP-1s through Medicaid as of this year.
This matters because we're talking about medications that can cost $800-$1,200 per month without insurance. For people on Medicare who've been completely shut out, this could be huge.
The program will work through Medicare Part D plans, which means your specific coverage will depend on which plan you choose. It's not going to be automatic coverage for everyone, but it's a massive shift from the current "absolutely not" policy.
Your Liver Really Loves These Drugs
While we're talking about benefits, researchers at the University of Toronto just discovered something pretty cool about semaglutide. Turns out, it's doing great things for your liver that have nothing to do with weight loss.
The study found that semaglutide works directly on liver cells to improve how your liver functions. This isn't just a side effect of losing weight - it's happening independently. For people dealing with metabolic liver disease, this could mean getting liver benefits from lower doses without dealing with the nausea and other side effects that come with higher doses used for weight loss.
What's interesting is that doctors might start prescribing these medications specifically for liver health, not just diabetes or weight management. That expands who might benefit from GLP-1s way beyond what most people think.
Why This All Matters Right Now
These two pieces of news actually connect in an important way. Better insurance coverage means more people can access these drugs, and now we know they're helping with health issues we didn't even realize before.
If you're currently struggling to afford Wegovy or similar medications, the Medicare changes won't help immediately unless you're already on Medicare. But it signals that insurance coverage for GLP-1s is shifting in a big way. Other insurance companies often follow Medicare's lead on coverage decisions.
For people with liver issues, this research might open up new conversations with your doctor about whether a GLP-1 could help, even if weight loss isn't your primary goal.
Bottom Line
Medicare covering GLP-1s for weight loss is a massive policy shift that could help millions of people who've been priced out of these medications. And learning that these drugs help your liver independently of weight loss just adds another reason why insurance companies should be covering them. If you're on Medicare, start asking your doctor about these programs. If you're not, this could be the beginning of broader coverage changes across all insurance types.
